Even as COVID-19 was correlated with worse outcomes for people with asthma, the number of people receiving care for asthmatic episodes decreased during the pandemic, according to three studies published in Thorax. Two focused on the United Kingdom, the first a study in England comparing general practitioner (GP) visits and hospital admissions, and the other…
Everyone agrees about the good news — folks whose asthma is spurred on by allergies don’t appear to have an increased risk of life-threatening illness if they contract COVID-19. “Asthma has not risen as one of the top comorbid diseases for worse COVID-19 outcomes,” said Dr. Sandhya Khurana, director of the Mary Parkes Center for…
After stay-at-home orders were issued this spring because of COVID-19, doctors at Children’s Hospital of Philadelphia noticed a dramatic drop in the number of patients who were being admitted for asthma emergencies or seeing their doctors for outpatient visits. In a new study, doctors there noted the drops were significant: the hospital and its care…
New findings suggest differing chronic lung diseases are associated with varying risk factors among COVID-19 patients. A pre-print article from a team of investigators at Brigham and Women’s Hospital and Harvard Medical School highlight the important of distinguishing asthma from chronic pulmonary conditions in interpreting patient risks due to coronavirus 2019 (COVID-19). The findings, which…
However, study finds allergic asthma did not significantly increase the risk of severe illness. Adults with asthma who became infected with the coronavirus that causes COVID-19 were at higher risk of developing severe illness compared with adults who did not have asthma, according to a new study led by researchers at Harvard T.H. Chan School…
MD Spiro prides itself on not only offering incredible spirometry products for your practice, but also prides itself on providing articles and industry updates for our customers. Below is a new study showing you trends, R&D progress, and predicted revenues in Asthma and COPD Therapies. So where’s the asthma and COPD therapies market heading? Visiongain’s…